Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
subjects to compare the single dose bioavailability of Torrent's Pioglitazone Hydrochloride
Tablets 1 × 45 mg and Actos® Tablets 1 × 45 mg of Takeda Pharmaceuticals America, Inc. Dosing
periods of studies were separated by a washout period of 12 days and 11 days respectively.
Study Design:
Randomized, Two-Way Crossover, Single-Dose, and Open-Label